| Literature DB >> 17327828 |
Sudha Nallasamy1, Prasuna C Paluru, Marcella Devoto, Nora F Wasserman, Jie Zhou, Terri L Young.
Abstract
PURPOSE: Myopia is a common, complex disorder, and severe forms have implications for blindness due to increased risk of premature cataracts, glaucoma, retinal detachment, and macular degeneration. Autosomal dominant (AD) non-syndromic high-grade myopia has been mapped to chromosomes 18p11.31, 12q21-23, 17q21-23, 7q36, 2q37.1, 7p15.3, 15q12-13, 3q26, 4q12, 8p23, 4q22-q27, 1p36, and Xq23-q25. Here, we demonstrate evidence of linkage for AD non-syndromic high-grade myopia in a large Hutterite family to a locus on chromosome 10q21.1.Entities:
Mesh:
Year: 2007 PMID: 17327828 PMCID: PMC2633468
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Clinical characteristics of pedigree MYO-101.
| 7242 | F | NA | 40 | 56 | +0.25 +0.75x79 | +0.25 +0.50x77 | --- |
| 7243 | M | UK | 14 | 32 | -2.25 +0.25x90 | -1.75 sphere | --- |
| 7244 | M | NA | --- | 19 | -0.25 sphere | Plano | --- |
| 7245 | F | A | 15 | 22 | -3.75 +0.75x90 | -5.25 +1.25x90 | --- |
| 7246 | F | UK | 14 | 17 | -3.00 sphere | -2.25 +0.25x110 | --- |
| 7247 | F | UK | 14 | 15 | -2.00 sphere | -1.50 +1.00x80 | --- |
| 7248 | M | UK | 10 | 21 | -2.00 +0.50x176 | -2.75 +1.50x165 | --- |
| 7249 | M | NA | 30 | 54 | +2.50 sphere | +2.50 sphere | --- |
| 7251 | F | A | 6 | 9 | -5.50 +0.75x95 | -6.00 +1.25x90 | --- |
| 7252 | F | A | 7 | 12 | -8.00 +1.25x90 | -6.50 +0.25x90 | --- |
| 7253 | F | A | 14 | 60 | -11.25 +0.75x105 | -12.25 +0.75x45 | --- |
| 7254 | M | A | 16 | 31 | -5.50 +0.50x155 | -9.00 +3.50x60 | --- |
| 7255 | M | NA | 45 | 48 | -0.50 +0.25x61 | -0.25 +0.50x90 | --- |
| 7256 | M | NA | --- | 32 | -0.50 sphere | +0.25 sphere | --- |
| 7257 | M | NA | --- | 26 | -0.75 +1.00x75 | -0.25 +0.25x95 | --- |
| 7258 | F | UK | 14 | 33 | -3.00 +1.25x90 | -1.25 +0.75x90 | --- |
| 7259 | M | NA | 17 | 33 | -1.25 -1.25x125 | -1.50 -0.75x50 | --- |
| 7260 | M | NA | 30 | 69 | +0.50 +1.00x9 | -1.25 +0.50x16 | --- |
| 7261 | F | NA | 15 | 59 | +1.25 +0.25x2 | +1.00 +0.50x165 | --- |
| 7262 | M | NA | 15 | 59 | -0.75 +1.00x8 | -0.25 +0.50x174 | --- |
| 7263 | M | UK | 10 | 24 | -1.00 +0.50x75 | -2.50 +1.25x80 | --- |
| 7264 | F | UK | 19 | 47 | -2.75 +1.25x37 | -2.00 +0.75x150 | --- |
| 7266 | F | UK | 15 | 55 | -3.00 +1.25x30 | -2.5 +0.75x145 | --- |
| 7268 | F | UK | 9 | 54 | -4.25 +2.5x85 | -3.25 +2.75x70 | --- |
| 7270 | M | NA | --- | 9 | Plano | Plano | --- |
| 7272 | M | A | 13 | 31 | -4.25 +1.00x180 | -4.25 +1.00x164 | s/p LASIK |
| 7274 | M | A | 14 | 37 | -6.75 +3.75x90 | -4.75 +1.75x75 | --- |
| 7275 | M | NA | 50 | 61 | +0.5 +0.25x140 | Plano+0.75x170 | --- |
| 7277 | M | NA | --- | 35 | +0.25 +0.50x79 | +0.25 +0.25x105 | --- |
Clinical characteristics of pedigree MYO-101. A=Affected, NA= Not Affected, UK= Unknown, M= Male, F=Female, OD= right eye, OS= left eye, Plano=no refractive error.
Primers designed for mutation screening.
| PCDH15 | ||
| 1 | TCACTTGCAATCATTACTACTCTAT | GGCTGACGAACACAGTACAATA |
| 2 | AAAAATCCTGGCTCGCTCTA | AATGTGGCACAGGTAATTAACTATG |
| 3 | TTATTCCAAGTAAAGCATGA | TTTTCCTTTTTAAATATTAATATAC |
| 4 | AAATGAGTTAAAGAAACTGTTGT | TATTTTCTGTCTTATGCTAGATATA |
| 5 | GTTTTCTTGATATTTCTAAACAGTT | TGTACTGAATGAACGAGTGCT |
| 6 | AATAATAGTATCATTACTAATCTGG | GAGCTGATTTTTATGCTGTAACA |
| 7 | ATGAAGAAGTGAGTGGCACA | TTCTATTTTCAGATGATAAGCATGT |
| 8 | AAAATAAAATAACCATGTTGGACT | TTTTTGTTGTTGTTTTTTGAGACTG |
| 9 | AAATATTTCCTTGGAATTGA | TGAGTTTACTGTCTCAGACGTTATA |
| 10 | TAACATAAAACTGCCTACAGTAGCG | TTTGTTCCTCAGCTGATGAAGGG |
| 11 | TTAATTCTCTCTTCTCTAGCTTATG | ATTAGTTAAAAAGAGAACCCTATA |
| 12 | CCAGACATCTCTTTCAGTTCCATAC | TCTTAATACTTTCACGTGGAT |
| 13 | TAATTTCTTCATGAGCATATCGTAT | CCTTTCAAATTGTAAGATTACCTG |
| 14 | AAGAATACTTGCCGCGCTTC | TTGTTGGGGGAAAAAACGACATGGT |
| 15 | CAGATGGAATTTTCATTCACTAGAG | AACAACTGAATAAACAATGCAGTC |
| 16 | AGAAAACAGAAAGGGAAGTACAAC | GATACGAAATGTTTGATTTTACACC |
| 17 | TGATTACTGAGAGGGGAAA | TGTCAAGTCAAAGGTTGCAGC |
| 18 | TTCAGATAGACAAATGCCAGAA | AGTCTTGAAGAATATCCAGCACA |
| 19 | ATTGTCATTGTCATTTCCTCCTT | GGCACACAAACCCTAATAGCA |
| 20 | GTCCTCGTTAAATTGATGCTGT | TTGGAAAATCTATGTTATGGGTC |
| 21 | AATTGAGAGGATGGAAGGCT | TTGCTGTCTTGTGATTCGGTC |
| 22 | CCCAAAGCAACCATTAATTTTTC | ATGAGGATAGAGATCAAAACGCA |
| 23 | CACCTGGTAGGCAGTGAGGAAAT | TTGAAACCCCAAAATATAATGT |
| 24 | ATGAATGTGTGAGGGCAGAGGGT | CAAATGAGGAAAAGGGCAAGGT |
| 25 | TTAGCGAAGTATTGATGTTGA | TCCCAAGGTTTATCCAGAG |
| 26 | AAGCATCATTATCAGTGTCCC | CCTACTGGAGGAATACAAACC |
| 27 | CCCCTCCGTCTAGGCTACTGATA | AAACTGAAAACACTGACCTATGGCT |
| 28 | GTAGGGAAGAGGTAATGTGGG | AGACACTGAGGGCTCCAA |
| 29 | GGCTGTCATCATTTTTCATTT | TTCAGTAACTATTTGGTGGGT |
| 30 | GCTTGTGTTTCAATTAGAGAA | CGCAAAGCCATGTTAC |
| 31 | GAATGACTCTAACGGTAACGAT | TGGAAGCTATAGGCAAACTATCT |
| 32 | CCTGTGGGGATGCTTTTGTAA | AATTTCTGGTTTGGTTTTGGC |
| 33-1 | AACTTGTTTCCTTACATTTCA | CCTTGCCTTATTTCCT |
| 33-2 | AAGAGGTAGCAGCAATCCATT | CGGCAGGCATCAAGTT |
| 33-3 | CCCTCCACCTCCTTCAG | TGGTTTAAGTTGGGTATCTAA |
| 33-4 | TTTTAGTGGGAATATGTGGG | AAAAAATTTAAATTAGGGAGATGAT |
| ZWINT | ||
| 1 | GTGGATGTGGGGAGCGGCGAACGG | AAGAACTTCCACAGGCGCGCGGTCGAG |
| 2 and 3 | GTCTTCAGAAGCCAAGGGGTCG | CCCTGCTGATTTTCCTTTTGGCACGTA |
| 3 and 4 | GGCCATTTGTTTCTACAGATAAGCAAG | GTGGTGGTATGTACAAGATGAGAGCGA |
| 5 | TCAAAGGAGGAAGCAAAACGGTTTTC | CCAAGGTACACCCAGGGGTCTTGAGTA |
| 6 and 7 | CAAATTTACATCTCCAGCAGGTTGTAG | GCAAGAATGCCTCACCCTAGAAC |
| 8 | GAGCTCACTGTTATAATTCTGGTTCAC | AGGTAAATGAGAGATGGAACAGG |
| 9a | CTTTAAATAACTTGAGACATTGCTAAC | TAATAAACTTTGAAATTTGGTGAGT |
| 9b | AAATGCATTCTTTCCAAACCTATGTGA | GGTTTGAACACAGGGTGTGCAG |
Forward and reverse primers designed for PCDH15 and ZWINT for mutation screening.
Figure 1Pedigree MYO-101 with familial high-grade myopia. Circles and squares indicate females and males, respectively, while solid symbols show affected individuals. The alleles for the most informative polymorphic markers are shown for each studied individual. Haplotypes were constructed based on the minimum number of recombinations between these markers. The solid and crosshatched bars indicate the two affected haplotypes.
Figure 2Multipoint LOD score data for pedigree MYO-101 for chromosome 10q21.1 with markers labeled along the X-axis. LOD scores were plotted against marker distance in centiMorgans (cM).
Figure 3Schematic representation of a linkage map of microsatillite markers located at 10q21.1. The mapping order and genetic distances (in centiMorgans [cM]) were primarily obtained from the human genetic map of the Marshfield Center for Medical Genetics. The bold segment denotes the linked interval determined by multipoint linkage and haplotype analysis.
Observed sequence polymorphisms in the protocadherin 15 (PCDH15) and ZW10 interacter (ZWINT) genes.
| PCDH15 | ||||||
| Exon 2 | 83 bp in Exon 2 | T | T/G | rs11004439 | Ser->Ala | C009, 7256 |
| Intron 2 | 50 bp, 5' of Exon 3 | T | G | rs10825347 | - | C009, 7252, 7253 |
| 50 bp, 5' of Exon 3 | T | G/T | rs10825347 | - | 7254, 7245, 7251, 7274, 7256, 7257 | |
| Intron 3 | 4 bp, 3'of Exon3 | A | A/G | Novel | - | 7254, 7251 |
| Intron 4 | 31 bp, 5'of Exon5 | T | T/C | rs11594958 | - | 7256 |
| Intron 7 | 9 bp, 5'of Exon8 | C | C/T | rs10740579 | - | C009, 7257, 7272 |
| 9 bp, 5'of Exon8 | C | T | rs10740579 | - | 7254, 7256 | |
| Exon 8 | 4 bp in Exonic | C | C/T | Novel | Ala->Thr | C009 |
| Intron 9 | 57 bp, 3'of Exon8 | T | G | rs10763098 | - | 7254 |
| 57 bp, 3'of Exon8 | T | G/T | rs10763098 | - | C009, 7256, 7257, 7272 | |
| Intron 9 | 71 bp, of 5' Exon 9 | G | A | Novel | - | 7254, 7245 |
| 71 bp, of 5' Exon 9 | G | G/A | Novel | - | C009, 7256, 7257, 7252, 7251 | |
| Intron 13 | 23 bp, of3' Exon13 | G | G/A | rs7093302 | - | C009, 7256, 7257, 7252, 7274, 7251 |
| Intron 14 | 43 bp, of5' Exon 15 | - | Insertion A | Novel | - | C009, 7254, 7256, 7257, 7272 |
| Intron 17 | 141 bp, 3' of Exon 17 | C | C/T | Novel | - | 7254, 7257 |
| Intron 20 | 37 bp, 3' of Exon 20 | C | C/T | Novel | - | 7256, 7272 |
| Exon 21 | 35 bp in Exon 21 | G | G/A | rs2135720 | Ile->Ile | 7256, 7272 |
| Intron 21 | 109 bp, 5' of Exon 22 | T | T/C | Novel | - | C009, 7254 |
| Intron 22 | 48 bp, 5' of Exon 23 | G | G/A | rs2593107 | - | C009, 7254 |
| Intron 25 | 72 bp, 5' of Exon 26 | A | A/G | Novel | - | C009, 7254 |
| Intron 25 | 68 bp, 5' of Exon 26 | T | T/G | Novel | - | 7254, 7257 |
| Intron 29 | 20 bp, 5' of Exon 30 | C | C/T | Novel | - | C009, 7254, 7256, 7257, 7272 |
| Intron 31 | 188 bp, 3' Exon 31 | C | C/T | Novel | - | C009, 7254, 7256, 7257, 7272 |
| Intron 32 | 120 bp, 3' of Exon 33 | T | T/C | Novel | - | C009, 7254, 7256, 7257, 7272 |
| Exon 33 | 215 bp, of Exon 33 | C | C/A | Novel | Leu->Leu | 7256, 7272 |
| ZWINT | ||||||
| Intron5 | 30 bp, 5' of Exon 4 | C | C/T | Novel | - | 7254, 7257 |
| Intron 3 | 74 bp, 3' of Exon 3 | G | A/A | rs3861049 | - | C009, 7254, 7256, 7257, 7272 |
Affected individual sample numbers are in red. C009, external control; rs, public reference single nucleotide polymorphism (SNP) number from the dbSNP database. Note: Samples C009, 7254, 7256, 7257, and 7272 were sequenced for all exons. Additional samples were sequenced for exons with polymorphisms that initially appeared to segregate with high-grade myopia.